» Articles » PMID: 1329097

Cyclic Amplification and Selection of Targets for Multicomponent Complexes: Myogenin Interacts with Factors Recognizing Binding Sites for Basic Helix-loop-helix, Nuclear Factor 1, Myocyte-specific Enhancer-binding Factor 2, and COMP1 Factor

Overview
Specialty Science
Date 1992 Oct 15
PMID 1329097
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Myogenin is one of four muscle-specific basic helix-loop-helix regulatory factors involved in controlling myogenesis. We here describe various protein complexes that increase the affinity of myogenin for DNA. We mixed an oligonucleotide containing a degenerate center large enough to accommodate multiple binding sites with crude myotube nuclear extracts and used cyclic amplification and selection of targets with an antimyogenin monoclonal antibody to isolate protein-DNA complexes. Since each cycle of selection results in the enrichment for the sequences with the highest affinity, we isolated multicomponent sites in which myogenin binding was increased by its interaction with other DNA binding proteins. Myogenin interacts with members of the nuclear factor 1 family, the muscle-specific factor myocyte-specific enhancer-binding factor 2, and another factor, COMP1 (cooperates with myogenic proteins 1), that binds to the sequence TGATTGAC. Myogenin also exhibits cooperative binding with other proteins that recognize CANNTG motifs, and various constraints on spacing and orientation were observed. The application of this approach to other transcription factors should not only help identify the different functions of myogenin versus other members of the muscle basic helix-loop-helix regulatory family but also help define the general combinatorial mechanisms involved in eukaryotic gene regulation.

Citing Articles

Expression Levels of PF4, ALOX12, ITGA2B, F131A in Pregnant COVID-19 Survivors.

Shaker M, Abdelghany A, Elaraby N Biochem Genet. 2024; .

PMID: 39543003 DOI: 10.1007/s10528-024-10958-4.


Significant phenotypic variability in a multigenerational family with an missense mutation: Case series and review of the literature.

Paschell P, Laukaitis C Clin Case Rep. 2024; 12(1):e8307.

PMID: 38188845 PMC: 10769898. DOI: 10.1002/ccr3.8307.


Refining the Myostatin Gene Polymorphism through Worldwide Whole-Genome Sequencing.

Bruno S, Landi V, Senczuk G, Brooks S, Almathen F, Faye B Animals (Basel). 2022; 12(16).

PMID: 36009658 PMC: 9404819. DOI: 10.3390/ani12162068.


Actin-related protein 5 functions as a novel modulator of MyoD and MyoG in skeletal muscle and in rhabdomyosarcoma.

Morita T, Hayashi K Elife. 2022; 11.

PMID: 35348112 PMC: 8983046. DOI: 10.7554/eLife.77746.


Stable intronic sequence RNAs (sisRNAs) are selected regions in introns with distinct properties.

Jin J, He X, Silva E BMC Genomics. 2020; 21(1):287.

PMID: 32264855 PMC: 7137253. DOI: 10.1186/s12864-020-6687-9.


References
1.
Murre C, McCaw P, Vaessin H, Caudy M, Jan L, Jan Y . Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell. 1989; 58(3):537-44. DOI: 10.1016/0092-8674(89)90434-0. View

2.
Braun T, Bober E, Winter B, Rosenthal N, Arnold H . Myf-6, a new member of the human gene family of myogenic determination factors: evidence for a gene cluster on chromosome 12. EMBO J. 1990; 9(3):821-31. PMC: 551742. DOI: 10.1002/j.1460-2075.1990.tb08179.x. View

3.
DE Wet J, Wood K, DeLuca M, Helinski D, Subramani S . Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol. 1987; 7(2):725-37. PMC: 365129. DOI: 10.1128/mcb.7.2.725-737.1987. View

4.
Rhodes S, Konieczny S . Identification of MRF4: a new member of the muscle regulatory factor gene family. Genes Dev. 1989; 3(12B):2050-61. DOI: 10.1101/gad.3.12b.2050. View

5.
Braun T, Bober E, Tannich E, Arnold H . A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts. EMBO J. 1989; 8(3):701-9. PMC: 400865. DOI: 10.1002/j.1460-2075.1989.tb03429.x. View